Papers

15

Total Citations

113

H-Index

6

About

Masakatsu Numata is a leading colorectal surgeon whose research is reshaping the landscape of minimally invasive cancer surgery, with a particular focus on robotic-assisted techniques for rectal and colon cancer. His work addresses critical challenges in surgical oncology, including the management of locally advanced disease, the prevention of anastomotic leakage, and the preservation of functional outcomes. Numata’s contributions are grounded in rigorous prospective trials, such as the multicentre VITRUVIANO trial (17 citations), which assesses the feasibility of robotic surgery for advanced rectal cancer, and the ROBOCOLO trial (7 citations), which evaluates robotic right-sided colectomy. He has also pioneered a standardized seven-step dissection technique for robotic total mesorectal excision (9 citations), enhancing surgical precision and reproducibility. Beyond technical innovation, Numata has led landmark studies on patient quality of life, including the LANDMARC study (8 citations), which comprehensively investigates male sexual dysfunction after minimally invasive rectal cancer surgery. With over 100 total citations across his most-cited works, Numata’s research is not only advancing surgical practice but also ensuring that patient-centered outcomes remain at the forefront of oncologic care.

Research Focus

Key Achievements

6
H-Index
15
Papers
113
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center
29 citations · 2017
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 104
🏛 Institutions: Shizuoka Cancer Center, Yokohama City University, Yokohama City University Medical Center, Kanagawa Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago